GMI-1271, a Potent E-Selectin Antagonist, in Combination with Chemotherapy in Relapsed Refractory AML: A Novel, Well-Tolerated Regimen with a High Remission Rate Daniel J. DeAngelo*1, Brian A. Jonas2, Jane L. Liesveld3, - The Kilns - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2017-06-26 08:58:58		GMI-1271, a Potent E-Selectin Antagonist, in Combination with Chemotherapy in Relapsed/Refractory AML: A Novel, Well-Tolerated Regimen with a High Remission Rate Daniel J. DeAngelo*1, Brian A. Jonas2, Jane L. Liesveld3, Add to Reading List Source URL: glycomimetics.com Download Document from Source Website File Size: 729,11 KB Share Document on Facebook